-
EP3917616
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3917616
| EP3917616 - HETEROCYCLIC COMPOUND AND USE THEREOF [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 02.12.2022 Database last updated on 22.08.2024 | |
| Former | Request for examination was made Status updated on 05.11.2021 | ||
| Former | The international publication has been made Status updated on 08.08.2020 | ||
| Former | unknown Status updated on 18.03.2020 | Most recent event Tooltip | 14.08.2024 | New entry: Despatch of examination report + time limit | Applicant(s) | For all designated states Takeda Pharmaceutical Company Limited 1-1, Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045 / JP | [2021/49] | Inventor(s) | 01 /
HATTORI, Yasushi c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 26-1 Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012 / JP | 02 /
MIYANOHANA, Yuhei c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 26-1 Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012 / JP | 03 /
KAJITA, Yuichi c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 26-1 Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012 / JP | 04 /
KOIKE, Tatsuki c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 26-1 Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012 / JP | 05 /
HOASHI, Yasutaka c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 26-1 Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012 / JP | 06 /
TOKUNAGA, Norihito c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 26-1 Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012 / JP | 07 /
PAWLICZEK, Alexander Martin c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 26-1 Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012 / JP | 08 /
ODA, Tsuneo c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 26-1 Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012 / JP | 09 /
MIYAZAKI, Tohru c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 26-1 Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012 / JP | 10 /
ITO, Yoshiteru c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 26-1 Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012 / JP | 11 /
TAKEUCHI, Kohei c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 26-1 Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012 / JP | 12 /
IMAMURA, Keisuke c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 26-1 Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012 / JP | 13 /
SUGIMOTO, Takahiro c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED, 26-1 Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 2510012 / JP | [N/P] |
| Former [2021/49] | 01 /
HATTORI, Yasushi Fujisawa-shi, Kanagawa 2510012 / JP | ||
| 02 /
MIYANOHANA, Yuhei Fujisawa-shi, Kanagawa 2510012 / JP | |||
| 03 /
KAJITA, Yuichi Fujisawa-shi, Kanagawa 2510012 / JP | |||
| 04 /
KOIKE, Tatsuki Fujisawa-shi, Kanagawa 2510012 / JP | |||
| 05 /
HOASHI, Yasutaka Fujisawa-shi, Kanagawa 2510012 / JP | |||
| 06 /
TOKUNAGA, Norihito Fujisawa-shi, Kanagawa 2510012 / JP | |||
| 07 /
PAWLICZEK, Alexander Martin Fujisawa-shi, Kanagawa 2510012 / JP | |||
| 08 /
ODA, Tsuneo Fujisawa-shi, Kanagawa 2510012 / JP | |||
| 09 /
MIYAZAKI, Tohru Fujisawa-shi, Kanagawa 2510012 / JP | |||
| 10 /
ITO, Yoshiteru Fujisawa-shi, Kanagawa 2510012 / JP | |||
| 11 /
TAKEUCHI, Kohei Fujisawa-shi, Kanagawa 2510012 / JP | |||
| 12 /
IMAMURA, Keisuke Fujisawa-shi, Kanagawa 2510012 / JP | |||
| 13 /
SUGIMOTO, Takahiro Fujisawa-shi, Kanagawa 2510012 / JP | Representative(s) | Jones, Nicholas Andrew Withers & Rogers LLP 2 London Bridge London SE1 9RA / GB | [2021/49] | Application number, filing date | 20709748.6 | 30.01.2020 | [2021/49] | WO2020JP04444 | Priority number, date | JP20190015488 | 31.01.2019 Original published format: JP 2019015488 | [2021/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020158958 | Date: | 06.08.2020 | Language: | EN | [2020/32] | Type: | A1 Application with search report | No.: | EP3917616 | Date: | 08.12.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.08.2020 takes the place of the publication of the European patent application. | [2021/49] | Search report(s) | International search report - published on: | EP | 06.08.2020 | Classification | IPC: | A61P3/00, A61K31/40, A61K31/4025, A61K31/422, A61K31/427, A61K31/4439, C07D207/14, C07D401/10, C07D403/10, C07D403/14, C07D407/06, C07D413/10, C07D417/10 | [2021/49] | CPC: |
C07D207/14 (EP,IL,KR,US);
C07D405/06 (KR);
A61K31/40 (EP,IL,KR);
A61K31/4025 (EP,IL,KR);
A61K31/422 (EP,IL);
A61K31/427 (EP,IL);
A61K31/4439 (EP,IL,KR);
A61K31/506 (KR);
A61P25/00 (EP,IL,KR);
A61P3/00 (EP,IL);
C07D401/10 (EP,IL,KR);
C07D403/06 (KR,US);
C07D403/10 (EP,IL,KR);
C07D403/14 (EP,IL,KR);
C07D407/06 (EP,IL,KR);
C07D407/08 (IL,KR,US);
C07D413/10 (EP,IL,KR);
C07D417/06 (IL,KR,US);
C07D417/10 (EP,IL,KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/49] | Title | German: | HETEROCYCLISCHE VERBINDUNG UND VERWENDUNG DAVON | [2021/49] | English: | HETEROCYCLIC COMPOUND AND USE THEREOF | [2021/49] | French: | COMPOSÉ HÉTÉROCYCLIQUE ET SON UTILISATION | [2021/49] | Entry into regional phase | 06.07.2021 | National basic fee paid | 06.07.2021 | Designation fee(s) paid | 06.07.2021 | Examination fee paid | Examination procedure | 06.07.2021 | Amendment by applicant (claims and/or description) | 06.07.2021 | Examination requested [2021/49] | 06.07.2021 | Date on which the examining division has become responsible | 02.12.2022 | Despatch of a communication from the examining division (Time limit: M04) | 12.04.2023 | Reply to a communication from the examining division | 13.08.2024 | Despatch of a communication from the examining division (Time limit: M04) | Fees paid | Renewal fee | 20.01.2022 | Renewal fee patent year 03 | 19.01.2023 | Renewal fee patent year 04 | 23.01.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2012137982 (TAKEDA PHARMACEUTICAL [JP], et al); | [AD]WO2017135306 (TAKEDA PHARMACEUTICALS CO [JP]); | [AP]WO2019027058 (TAKEDA PHARMACEUTICALS CO [JP]); | by applicant | WO0100663 | WO2012137982 | WO2015048091 | WO2015073707 | WO2015147240 | WO2017135306 | WO2018164191 | WO2018164192 | WO2019027003 | WO2019027058 | WO2020004536 | WO2020004537 |